A61K 38/35
Corticotropin [acth]
Official title: Corticotropin [ACTH]
A61K38/35 (Corticotropin [acth]) appears on 53 US grants and 85 published applications in this corpus.
Search patents in A61K- Granted patents
- 53
- Published applications
- 85
- Assignees
- 48
- Inventors
- 150
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 3 |
| 2003 | 1 | 0 |
| 2004 | 2 | 2 |
| 2005 | 0 | 4 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
| 2010 | 1 | 12 |
| 2011 | 0 | 3 |
| 2012 | 5 | 3 |
| 2013 | 4 | 5 |
| 2014 | 1 | 6 |
| 2015 | 1 | 4 |
| 2016 | 2 | 2 |
| 2017 | 2 | 3 |
| 2018 | 1 | 2 |
| 2019 | 2 | 7 |
| 2020 | 0 | 3 |
| 2021 | 1 | 4 |
| 2022 | 4 | 4 |
| 2023 | 1 | 2 |
| 2024 | 3 | 5 |
| 2025 | 6 | 4 |
| 2026 | 3 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Kits for preparing and delivering purified corticotropin15 Sep 2026US 12,734,217 B1ANI Pharmaceuticals, Inc.
- Methods of administering chimeric antigen receptor immunotherapy18 Aug 2026US 12,709,639 B2Kite Pharma, Inc.
- Method of diagnosis of adrenal insufficiency5 May 2026US 12,616,736 B2Sheffield Children's NHS Foundation Trust
- Kits for preparing and delivering purified corticotropin14 Oct 2025US 12,440,542 B1ANI Pharmaceuticals, Inc.
- Kits for preparing and delivering purified corticotropin10 Jun 2025US 12,324,787 B1ANI Pharmaceuticals, Inc.
- Methods of promoting remyelination15 Jan 2026US 2026/0014235 A1Mallinckrodt Pharmaceuticals Ireland Limited
- Pre-filled manual injector apparatus14 Aug 2025US 2025/0255937 A1Mallinckrodt Pharmaceuticals Ireland Limited
- Combination therapy with adp-ribose binding peptide and adp-ribose for prevention or treatment of cancer7 Aug 2025US 2025/0250310 A1PearlsInMires Co., Ltd.
- Protein biomarkers of inflammatory activity in multiple sclerosis12 Jun 2025US 2025/0189541 A1Oklahoma Medical Research Foundation
- Materials and methods for treating stress-related disorders and cancer5 Jun 2025US 2025/0179168 A1University of Florida Research Foundation, Inc.
Most cited
By later US patents
- Modulated release from biocompatible polymers263US 5,656,297 AAlkermes Controlled Therapeutics, Inc. · 1997
- Modulated release from biocompatible polymers226US 5,912,015 AAlkermes Controlled Therapeutics, Inc. · 1999
- Controlled release ACTH containing microspheres95US 5,413,797 AAlkermes Controlled Therapeutics, Inc. · 1995
- Physiologically active polypeptide-containing pharmaceutical composition85US 5,929,027 ATeikoku Seiyaku Co., Ltd. · 1999
- SARMS and method of use thereof43US 7,772,433 B2University of Tennessee Research Foundation · 2010